23 September 2024
23 September 2024
Data showed non-inferiority of immune response between adults and adolescents with Imvanex.
The regulatory decision was informed by a comprehensive submission, including a usability study.
The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.
The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.
The approval was based on results from two studies, FRESCO-2 and FRESCO.
After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS patients.
The CHMP’s recommendations will now be reviewed by the European Commission for marketing authorisation.
The asset has also been granted a rare paediatric disease priority review voucher.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Give your business an edge with our leading industry insights.
